Atomoxetine (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Atomoxetine drug offered from Teva Pharmaceuticals USA, Inc.. This Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
NON-PROPRIETARY NAME: | Atomoxetine |
SUBSTANCE NAME: | ATOMOXETINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-05-30 |
END MARKETING DATE: | 0000-00-00 |
Atomoxetine HUMAN PRESCRIPTION DRUG Details:
Item Description | Atomoxetine from Teva Pharmaceuticals USA, Inc. |
LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2017-05-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0093-3542_84f539d8-946c-4619-81fe-693558d96659 |
PRODUCT NDC: | 0093-3542 |
APPLICATION NUMBER: | ANDA079022 |
Other ATOMOXETINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: